Proflexa
Product Images NDC 83011-001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Proflexa (NDC 83011-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sinoveda Canada Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Proflexa Us Label Changes Pending (v3) Page 001)

1 (Proflexa Us Label Changes Pending (v3) Page 001)
PROFLEXA Topical Pain Relief Cream is a medication with 3.3% camphor that can help relieve minor aches and pains from muscles and joints, associated with sprains, simple backache, bruises, and arthritis. It is intended for external use and should not be applied to damaged skin, wounds, or the eyes. If symptoms persist or worsen, consult a doctor. Pregnant and breastfeeding women should consult their doctor before use. Children under two years old should consult a doctor. This medication contains natural ingredients such as grapefruit seed extract, grape seed oil, frankincense gum/resin extract, clove flower oil, and shea butter. For any questions or comments, contact the manufacturer's customer service.*
FDA Label Image

2 (Proflexa Us Label Changes Pending (v3) Page 002)

2 (Proflexa Us Label Changes Pending (v3) Page 002)
NDC #:83011-001-01 is a pain relief cream for muscles and joints called RADIATE PROFLUXA. It is manufactured by Sinouada Canacane in Canada and includes 3.3% camphor as one of its ingredients. Contact information for the manufacturer is also provided.*
FDA Label Image

3 (Proflexa Us Label Changes Pending (v3) Page 003)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.